IL6 and mastitis: Several studies have showed that the modulation of ERK and MAPK signaling pathway can lead to anti-inflammatory role in mastitis due to the decreased release of pro-inflammatory cytokines such as tumor necrosis factor-α, IL-1β, and IL-6 [56–59].